PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB

The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof. La présente invention concerne des com...

Full description

Saved in:
Bibliographic Details
Main Authors ELBAZ, FRANTZ, STINGELIN, DORIS, KOCHHAR, CHARU, BOCK, MICHAELA ANNA MARIA
Format Patent
LanguageEnglish
French
Published 19.09.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof. La présente invention concerne des comprimés dispersibles comprenant le composé de (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-méthyl-5-[2-(2,2,2-trifluoro-1,1-diméthyl-éthyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) ou un sel pharmaceutiquement acceptable de celui-ci.
Bibliography:Application Number: CA20152962714